374 related articles for article (PubMed ID: 28403788)
41. Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer.
Khan S; Chang SH; Hicks V; Wang M; Grubb RL; Drake BF
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):707-712. PubMed ID: 34811499
[TBL] [Abstract][Full Text] [Related]
42. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
43. Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies.
Nimako GK; Wintrob ZA; Sulik DA; Donato JL; Ceacareanu AC
J Pharm Pract; 2017 Apr; 30(2):185-194. PubMed ID: 26811340
[TBL] [Abstract][Full Text] [Related]
44. Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.
Hamada T; Khalaf N; Yuan C; Morales-Oyarvide V; Babic A; Nowak JA; Qian ZR; Ng K; Rubinson DA; Kraft P; Giovannucci EL; Stampfer MJ; Fuchs CS; Ogino S; Wolpin BM
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1300-1306.e3. PubMed ID: 29474971
[TBL] [Abstract][Full Text] [Related]
45. Statins use and the prognosis of colorectal cancer: a meta-analysis.
Li L; Cui N; Hao T; Zou J; Jiao W; Yi K; Yu W
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101588. PubMed ID: 33662632
[TBL] [Abstract][Full Text] [Related]
46. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
47. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.
Manthravadi S; Shrestha A; Madhusudhana S
Int J Cancer; 2016 Sep; 139(6):1281-8. PubMed ID: 27176735
[TBL] [Abstract][Full Text] [Related]
48. Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis.
Xin W; Fang L; Fang Q; Zheng X; Huang P
Mol Clin Oncol; 2018 Mar; 8(3):483-488. PubMed ID: 29468063
[TBL] [Abstract][Full Text] [Related]
49. Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.
Ambe CM; Mahipal A; Fulp J; Chen L; Malafa MP
PLoS One; 2016; 11(3):e0151632. PubMed ID: 26967162
[TBL] [Abstract][Full Text] [Related]
50. The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis.
Hu J; Fan HD; Gong JP; Mao QS
BMC Gastroenterol; 2023 Feb; 23(1):50. PubMed ID: 36829129
[TBL] [Abstract][Full Text] [Related]
51. Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality - An umbrella review.
Nowicka Z; Matyjek A; Płoszka K; Łaszczych M; Fendler W
Pancreatology; 2023 Mar; 23(2):192-200. PubMed ID: 36697348
[TBL] [Abstract][Full Text] [Related]
52. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis.
Zhou DC; Gong H; Tan CQ; Luo JQ
Oncotarget; 2017 Sep; 8(37):62349-62357. PubMed ID: 28977950
[TBL] [Abstract][Full Text] [Related]
54. The association between statin use and prognosis in esophageal cancer patients: A meta-analysis.
Lv J; Chen P; Wu J; Wen Z; Zhao C
Medicine (Baltimore); 2023 Mar; 102(12):e33359. PubMed ID: 36961185
[TBL] [Abstract][Full Text] [Related]
55. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract][Full Text] [Related]
56. Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients.
Choi M; Han J; Yang BR; Jang MJ; Kim M; Lee DW; Kim TY; Im SA; Lee HB; Moon HG; Han W; Noh DY; Lee KH
Cancer Res Treat; 2021 Jan; 53(1):65-76. PubMed ID: 32972040
[TBL] [Abstract][Full Text] [Related]
57. Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.
Xu H; Chen K; Jia X; Tian Y; Dai Y; Li D; Xie J; Tao M; Mao Y
Oncologist; 2015 Nov; 20(11):1236-44. PubMed ID: 26446233
[TBL] [Abstract][Full Text] [Related]
58. Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta-analysis.
Li Y; He X; Ding Y; Chen H; Sun L
Cancer Med; 2019 Jun; 8(6):3305-3313. PubMed ID: 31069997
[TBL] [Abstract][Full Text] [Related]
59. A Systematic Review and Meta-Analysis of Controlled Trials on the Effects of Statin and Fibrate Therapies on Plasma Homocysteine Levels.
Sahebkar A; Pirro M; Reiner Ž; Cicero A; Ferretti G; Simental-Mendía M; Simental-Mendía LE
Curr Med Chem; 2016; 23(39):4490-4503. PubMed ID: 27748179
[TBL] [Abstract][Full Text] [Related]
60. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
Tian S; Lei HB; Liu YL; Chen Y; Dong WG
Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
